{
  "ticker": "EVE",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02958531",
  "id": "02958531",
  "pages": 2,
  "price_sensitive": true,
  "date": "20250616",
  "time": "0838",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250616/pdf/06krwwcb0qdcgh.pdf",
  "summary": "- **Strategic Partnership**: EVE signs agreement with TeleDocs Clinic for nationwide prescribing and promotional support for Libbo+ (erectile dysfunction soluble film) and Dyspro (dysmenorrhea gummy).  \n- **Market Access**: TeleDocs is the first online clinic authorized to prescribe both products, leveraging its network of 3,500+ pharmacies.  \n- **Regulatory Timeline**: Products undergoing final testing; regulatory submissions and manufacturing expected Q3/Q4 2025.  \n- **Commercial Terms**: Two-year agreement with commitments for clinical training, digital education, and quarterly prescribing reporting.  \n\nNo material financial or capital markets impact disclosed.",
  "usage": {
    "prompt_tokens": 1009,
    "completion_tokens": 131,
    "total_tokens": 1140,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-15T22:59:59.563017"
}